๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-07-17

MRI Characterization of Mammographically Detected DCIS (NCT03495011)

MRI Characterization of Mammographically Detected Calcifications and Ductal Carcinoma in Situ

๐Ÿ”ต Active, Not Recruiting Interventional Protocol ๐Ÿ“Š Observational Clinical Research Sponsor: University of Washington

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

This is a single institution, prospective observational clinical trial for women with mammographically identified calcifications that may represent ductal carcinoma in situ (DCIS). The purpose of this study is to determine whether quantitative, multiparametric breast MRI performed prior to surgical resection can biologically characterize this common pre-invasive malignancy, ductal carcinoma in situ (DCIS), which typically presents in asymptomatic women as suspicious calcifications on mammography.

Who can join: Review the eligibility criteria below.

Location: Fred Hutch/University of Washington Cancer Consortium โ€” Seattle, Washington

Age range: 18 Years to 80 Years

๐Ÿงช Interventions in This Study

  • Breast MRI (DIAGNOSTIC_TEST)
  • Laboratory Biomarker Analysis (OTHER)

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • Fred Hutch/University of Washington Cancer Consortium โ€” Seattle, Washington

๐Ÿ“ž Contact the Study Coordinator

Phone: (855) 557-0555

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Breast Cancer, Stage 0

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Contact the study coordinator using the phone/email above.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—